Protein Expression Market is valued at USD 2298.94 Million in 2020 and expected to reach USD 4833.51 Million by 2027 with the CAGR of 11.20% over the forecast period. Global Protein Expression Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027– Increasing prevalence of chronic diseases is one of the major factors driving the growth of Global Protein Expression Market. Scope of Global Protein Expression Market ReportProteins are synthesized and regulated depending upon the functional need in the cell. The blueprints for proteins are stored in DNA, which is used as a template by highly regulated transcriptional processes to produce messenger RNA. Protein expression is a process through which proteins are modified, synthesized, and regulated in the cells. Protein expression is considered as an important element of proteomics, which enables the recombinant proteins expression in different host systems. Additionally, there are 3 methods of recombinant protein expressions such as chemical protein synthesis, in-vivo protein expression, and invitro protein expression. Biotechnology-based institutions are predominantly dependent on protein expression for the development of new therapeutics with minimum side effects.
Key Players for Protein Expression – Global Protein Expression report covers prominent player’s Agilent Technologies, Inc, Becton, Dickinson & Company, Bio Rad Laboratories, GenScript Biotech Corporation, LifeSensors Inc., Merck KGaA, Promega Corporation, QIAGEN N.V., Takara Holdings Inc., Thermo Fisher Scientific Inc. and others. NewsPolyplus-transfection Launched New Advanced System for Transient Protein Expression in CHO Cells July 6th, 2018; Polyplus-transfection SA, a biotechnology company offering innovative solutions for the delivery of nucleic acids for research, bioproduction and therapeutic applications, announced the launch of its FectoCHO Expression System. The new system is designed for enhanced protein production in CHO cells, showing outstanding protein yields even at low DNA amounts. The FectoCHO Expression System consists of three synergistically acting components such as FectoCHO CD Expression Medium, FectoPRO Transfection Reagent and FectoPRO Expression Booster. Increasing Prevalence of Chronic Diseases is one of the Major Factors Driving the Growth of Global Protein Expression Market. Rapidly growth in change in lifestyle and environmental factors is the major factor driving the growth of protein expression market. Increasing research activities in the pharmaceutical sector and growing prevalence of chronic diseases with increasing geriatric population are some of the major factors supplementing the market growth. The physiological changes that occur with aging are responsible for the higher probability of elderly individuals developing